Transaction · 0001765581-25-000026

Iannone Robert

Iannone Robert, EVP, GHR, D, CMO, reported a transaction classified as return at Jazz Pharmaceuticals plc involving 5239.000000 shares for an estimated $727959.05. Reported holdings after the transaction were 89104.000000 shares. The stored filing text includes a detected 10b5-1 reference.

returnSEC transaction code DEVP, GHR, D, CMO
JAZZJazz Pharmaceuticals plc
Filing timeMar 07
Trade dateMar 05, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

JAZZ price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
JAZZ since 2025-03-07Filed 545 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
return
Code D
Identifier
0001765581-25-000026
Ordinary Shares
Transaction date
Mar 05, 2025
Filed Mar 07, 2025, 11:49 PM · 2d delay
Shares
5.23k sh
$13.8k per share
Estimated value
-$72.7M
Computed from shares × price
Holdings after
89.1k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Global Head of R&D & CMO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

  2. F2

    This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

  3. F3

    Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.19 to $138.23. The price reported reflects the weighted average sale price. The Reporting Person here…

Original filing · 0001765581-25-000026
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

JAZZ